Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)
- Molitch, Mark E (Other)
- Huang, Wenyu (PD/PI)
Project: Research project